Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Moormeier, J.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

Breast Cancer in Black Women

Jill Moormeier, MD

15 May 1996 | Volume 124 Issue 10 | Pages 897-905

Purpose: To review the current knowledge about breast cancer in black women—including epidemiology, risk factors, screening practices, pathology, clinical manifestations, treatment, and outcome—with emphasis on issues that might explain why the survival rate in this population of women is lower than that in white women.

Data Sources: The MEDLINE database from 1966 to 1995 and the bibliographies of all related articles.

Study Selection: Review articles and clinical studies related to all aspects of breast cancer in black women.

Data Synthesis: The incidence of breast cancer is lower in black women (95.8 cases per 100 000 women) than in white women (112.7 cases per 100 000 women). Differences in reproductive factors may partially explain the lower risk for breast cancer among black women in the United States. Breast tumors in black women are consistently diagnosed at a more advanced stage of disease: Forty-two percent of black women present with cancer confined to the breast compared with 53% of white women. In addition, the cancers of black women tend to be more poorly differentiated and are less likely to be estrogen receptor positive. Treatment of breast cancer in black women appears to be similar to that in white women, but little is known about systemic therapy choices and efficacy. Overall, despite their lower risk for breast cancer, black women have a mortality rate from breast cancer similar to that of white women because they have a lower 5-year disease-specific survival rate (64% in black women compared with 80% in white women).

Conclusions: The discrepancy in survival rate between black and white women exists because black women have tumors that are more advanced at the time of diagnosis, because tumor biology in black women is different from that in white women (in particular, black women have a higher frequency of poorly differentiated tumors and a lower frequency of hormone receptor-positive tumors), and because of confounding comorbid conditions and socioeconomic factors. Current efforts to improve survival rates in black women with breast cancer should focus on community education, screening efforts, and early detection. As more information is gained about breast cancer treatment in black women, this may also be an important area for intervention.

Author and Article Information

From the University of Missouri-Kansas City School of Medicine, Kansas City, Missouri. For the current author address, see end of text.
Requests for Reprints: Jill Moormeier, MD, University of Missouri-Kansas City School of Medicine, 2411 Holmes Street, Kansas City, MO 64108.

This article has been cited by other articles:

				P. M. Lantz, M. Mujahid, K. Schwartz, N. K. Janz, A. Fagerlin, B. Salem, L. Liu, D. Deapen, and S. J. Katz The Influence of Race, Ethnicity, and Individual Socioeconomic Factors on Breast Cancer Stage at Diagnosis Am J Public Health, December 1, 2006; 96(12): 2173 - 2178. [Abstract] [Full Text] [PDF]

				G. Kimmick, F. Camacho, K. L. Foley, E. A. Levine, R. Balkrishnan, and R. Anderson Racial Differences in Patterns of Care Among Medicaid-Enrolled Patients With Breast Cancer J. Oncol. Pract, September 1, 2006; 2(5): 205 - 213. [Abstract] [Full Text] [PDF]

				N. A. Bickell, J. J. Wang, S. Oluwole, D. Schrag, H. Godfrey, K. Hiotis, J. Mendez, and A. A. Guth Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment J. Clin. Oncol., March 20, 2006; 24(9): 1357 - 1362. [Abstract] [Full Text] [PDF]

				N. Potischman, R. Troisi, R. Thadhani, R. N. Hoover, K. Dodd, W. W. Davis, P. M. Sluss, C.-C. Hsieh, and R. Ballard-Barbash Pregnancy Hormone Concentrations Across Ethnic Groups: Implications for Later Cancer Risk Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1514 - 1520. [Abstract] [Full Text] [PDF]

				S. S. Merkin, L. Stevenson, and N. Powe Geographic Socioeconomic Status, Race, and Advanced-Stage Breast Cancer in New York City Am J Public Health, January 1, 2002; 92(1): 64 - 70. [Abstract] [Full Text] [PDF]

				R. McKean-Cowdin, L. N. Kolonel, M. F. Press, M. C. Pike, and B. E. Henderson Germ-line HER-2 Variant and Breast Cancer Risk by Stage of Disease Cancer Res., December 1, 2001; 61(23): 8393 - 8394. [Abstract] [Full Text] [PDF]

				D. Buchwald, J. Sheffield, R. Furman, S. Hartman, M. Dudden, and S. Manson Influenza and Pneumococcal Vaccination Among Native American Elders in a Primary Care Practice Arch Intern Med, May 22, 2000; 160(10): 1443 - 1448. [Abstract] [Full Text] [PDF]

				M. U. Yood, C. C. Johnson, A. Blount, J. Abrams, E. Wolman, B. D. McCarthy, U. Raju, D. S. Nathanson, M. Worsham, and S. R. Wolman Race and Differences in Breast Cancer Survival in a Managed Care Population J Natl Cancer Inst, September 1, 1999; 91(17): 1487 - 1491. [Abstract] [Full Text] [PDF]